Transcriptomic and morphologic vascular aberrations underlying FCDIIb etiology
- PMID: 40199880
- PMCID: PMC11978774
- DOI: 10.1038/s41467-025-58535-6
Transcriptomic and morphologic vascular aberrations underlying FCDIIb etiology
Abstract
Focal cortical dysplasia type II (FCDII) is a major cause of drug-resistant epilepsy, but genetic factors explain only some cases, suggesting other mechanisms. In this study, we conduct a molecular analysis of brain lesions and adjacent areas in FCDIIb patients. By analyzing over 217,506 single-nucleus transcriptional profiles from 15 individuals, we find significant changes in smooth muscle cells (SMCs) and astrocytes. We identify abnormal vascular malformations and a unique type of SMC that we call "Firework cells", which migrate from blood vessels into the brain parenchyma and associate with VIM+ cells. These abnormalities create localized ischemic-hypoxic (I/H) microenvironments, as confirmed by clinical data, further impairing astrocyte function, activating the HIF-1α/mTOR/S6 pathway, and causing neuronal loss. Using zebrafish models, we demonstrate that vascular abnormalities resulting in I/H environments promote seizures. Our results highlight vascular malformations as a factor in FCDIIb pathogenesis, suggesting potential therapeutic avenues.
© 2025. The Author(s).
Conflict of interest statement
Competing interests: The authors declare no competing interests.
Figures
References
-
- Guerrini, R. & Barba, C. Focal cortical dysplasia: an update on diagnosis and treatment. Expert Rev. Neurother.21, 1213–1224 (2021). - PubMed
-
- Kapar, O. et al. Focal cortical dysplasia pathology: diagnostic difficulty, classification, and utility for pathogenesis. Neurosurg. Focus53, E6 (2022). - PubMed
-
- Pinheiro, J. & Honavar, M. Focal cortical dysplasia: Updates. Indian J. Pathol. Microbiol.65, S189–s197 (2022). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
